Effects of the tyrosine kinase inhibitor tyrphostin AG 556 on acute necrotising pancreatitis in rats

European Journal of Surgery

Volumn 168, Issue 10, 2002, Pages 557-562

  Alhan, Etem ^a,c   Çicek, Ramazan ^a   Erçin, Cengiz ^b   Örem, Asim ^a   Vanizor, Birgül ^a   Cinel, Akif ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

^b KOCAELI UNIVERSITY   (Turkey)

^c KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Acute pancreatitis; Tyrosine kinase inhibitor

Indexed keywords

ALANINE AMINOTRANSFERASE; AMYLASE; ASPARTATE AMINOTRANSFERASE; CALCIUM; DIMETHYL SULFOXIDE; MALONALDEHYDE; MYELOPEROXIDASE; N (4 BUTYLPHENYL) ALPHA CYANOCAFFEIC ACID AMIDE; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; RINGER LACTATE SOLUTION; TYRPHOSTIN; UREA;

ACINAR CELL; ACUTE HEMORRHAGIC PANCREATITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCITES; BLOOD PRESSURE; CALCIUM BLOOD LEVEL; CARDIOVASCULAR FUNCTION; CELL DAMAGE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME ASSAY; HEART RATE; HEMATOCRIT; HISTOLOGY; LABORATORY; LUNG; MALE; MEDICAL SCHOOL; MORTALITY; NONHUMAN; OUTCOMES RESEARCH; PANCREAS; PANCREAS INJURY; PRIORITY JOURNAL; RAT; SERUM; TREATMENT OUTCOME; TURKEY (REPUBLIC); UREA BLOOD LEVEL; URINARY EXCRETION;

ALANINE TRANSAMINASE; AMYLASES; ANIMALS; DIMETHYL SULFOXIDE; ENZYME INHIBITORS; FREE RADICAL SCAVENGERS; LUNG; MALE; MALONDIALDEHYDE; MODELS, ANIMAL; MULTIPLE ORGAN FAILURE; PANCREAS; PANCREATITIS, ACUTE NECROTIZING; PEROXIDASE; PROTEIN-TYROSINE KINASES; RATS; RATS, SPRAGUE-DAWLEY; TYRPHOSTINS;

EID: 0036997680     PISSN: 11024151     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Alhan E, Küçktülü U, Erçin C, Efe H. The effects of a calcium channel blocker and thyroid releasing hormone on acute pancreatitis in rats. Res Exp Med 1999; 199: 51-58.
2. Alhan E, Kücüktülü U, Ercin C, Deger O, Cicek R. The effects of dopexamine on acute necrotising pancreatitis in rats. Eur J Surg 2001; 167: 761-766.
3. Banks PA, Tenner S, Noordhoek EC, Sica G, Feng S, Zinner M. Does pancreatic necrosis predict severity in patients with acute necrotizing pancreatitis? Digestion 1996; 57: 218.
4. Beger HG, Bittner R, Büchler M. Hemodynamic data pattern in patients with acute pancreatitis. Gastroenterology 1986; 90: 74-79.
5. Buege TA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 1978; 52: 302-310.
6. Dong Zqi X, Fidler IJ. Tyrosine phosphorylation of mitogen activated protein kinases is necessary for activation of murine macrophages by natural and systemic bacterial products. J Exp Med 1993; 177: 1071-1077.
7. Fernandez del Castillo C, Rattner D, Makary M, Mostafavi A, McGrath D, Warshaw AL. Debridement and closed packing for the treatment of necrotizing pancreatitis. Ann Surg 1998; 225: 676-684.
8. Forgacs T, Eibl G, Faulhaber J, Kahran S, Buhr HJ, Foitzik T. Effect of fluid resuscitation with and without endothelin A receptor blockade on hemoconcentration and organ function in experimental pancreatitis. Eur Surg Res 2000; 32: 162-168.
9. Gross V, Leser HG, Heinrich A, Scholmerich J. Inflammatory mediators and cytokines - new aspects of the pathophysiology and assessment of severity of acute pancreatitis? Hepatogastroenterology 1993; 40: 552-530.
10. Jarrar D, Wang P, Song GY, Cioffi WG, Bland KI, Chaudry IH. Inhibition of tyrosine kinase signals after trauma -haemorrhage. Ann Surg 2001;23: 399-407.
11. Klar E, Mall G, Messmer K, Ratner DW, Herfarth C, Warshaw AL. Improvements of impaired pancreatic microcirculation by isovolemic hemodilution protects pancreatic morphology in acute biliary pancreatitis. Surg Gynecol Obstet 1993; 174: 144-150.
12. Klar E, Messmer K, Warshaw AL, Herfarth C. Pancreatic ischaemia in experimental acute pancreatitis: mechanism, significance and therapy. Br J Surg 1990; 77: 1205-1210.
13. Knoefel WT, Kollias N, Warshaw AL, Waldner H, Nishioda NS, Rattner DW. Pancreatic microcirculatory changes in experimental pancreatitis of graded severity in the rat. Surgery 1994; 116: 904-913.
14. Koj A. Initiation of acute phase response and synthesis of cytokines. Biochim Biophys Acta 1996; 1317: 84-94.
15. Lankisch PG, Pohl U, Otto J, Rahlf G. When should treatment of acute experimental pancreatitis be started? The early phase of of bile-induced acute pancreatitis. Res Exp Med 1988; 188: 123-129.
16. Lowry OH, Roseburgh NL, Farr AL, Randel RI. Protein measurement with folin phenol reagent. J Biol Chem 1951; 193: 265-275.
17. Norman J. The role of cytokines in the pathogenesis of acute pancreatitis. Am J Surg 1998; 1175: 76-83.
18. Norman J, Yang J, Fink G. Severity and mortality of experimental pancreatitis are dependent on interleukin-1 converting enzyme (ICE). J Interferon Cytokines Res 1997; 17: 113-118.
19. Novogrodsky A, Vanickin A, Patya M. Prevention of lipopolysaccaride-induced lethal toxicity by tyrosine kinase inhibitors. Science 1994; 264: 1319-1322
20. Raeder EM, Mansfield PJ, Hinksovska-Galcheva V. Sphingosine blocks human polymorphonuclear leukocyte phagocytosis through inhibition of mitogen -activated protein kinase activation. Blood 1999; 93: 686-693.
21. Rau B, Bauer A, Wang A, et al. Modulation of endogeneus nitric oxide synthase in experimental acute pancreatitis: Role of anti-ICAM-1 and oxygen free radical scavengers. Ann Surg 2001; 233: 195-203.
22. Rinderknecht H. Fatal pancreatitis, a consequence of excessive leukocyte stimulation? Int J Pancreatol 1994; 3: 105-112.
23. Schierwagen C, Bylund-Fellenius AC, Lundberg C. Improved method for quantification of tissue PMN accumalation measured by myeleperoxidase. J Pharmacol Methods 1990; 23:179-186.
24. Schoenberg MH, Büchler M, Beger HG. Oxygen radicals in experimental acute pancreatitis. Hepatogastroenterology 1994; 41: 313-319.
25. Schmidt J, Rattner MD, Lewandrowski K. A better model of acute pancreatitis for evaluating therapy. Ann Surg 1992; 215: 44-56.
26. Schmidt J, Lewandrowski K, Warshaw AL, Compton CC, Rattner DW. Morphometric characteristics and homogeneity of a new model of acute pancreatitis in the rat. Int J Pancreatol 1992; 12:41-51.
27. Schwartz M, Thomsen J, Meyer H, Büchler MW, Beger HG. Frequency and time course of pancreatic and extrapancreatic bacterial infection in experimental pancreatitis in rats. Surgery 2000; 127:427-432.
28. Sevransky JE, Shaked G, Novogrodsky A, et al. Tyrphostin AG 556 improves survival and reduces multiorgan failure in canine Escherichia coli peritonitis. J Clin Invest 1997; 99: 1966-1973.
29. Steer ML. Etiology and pathophysiology of acute pancreatitis. In: Go VLV, Diamagno EP, Gardner JD, Lebenthal E, Reber A, Scheele GA, eds. The pancreas: biology, pathophysiology, and disease. New York: Raven Press, 1993: 581-592.
30. Steer ML. The early intra acinar cell events that occur during acute pancreatitis. Pancreas 1998; 17: 31-37. Takeuchi, Sato S, Hashimoto K. Secretory and vascular responses to various biogenic and foreign substances of the perfused canine pancreas. Jpn J Pharmacol 1974; 24:57-73.
31. Steer ML. The early intra acinar cell events that occur during acute pancreatitis. Pancreas 1998; 17: 31-37. Takeuchi, Sato S, Hashimoto K. Secretory and vascular responses to various biogenic and foreign substances of the perfused canine pancreas. Jpn J Pharmacol 1974; 24:57-73.
32. Vanichkin A, Patya M, Gazit A, Levitzki A, Novogrodsky A. Late administration of lipophilic tyrosine kinase inhibiton prevents lipopolysaccaride and Escherichia coli-induced lethal toxicity. J Infect Dis 1996; 173: 927-933.
33. Weidenhach H, Lerch MM, Gress TM, Pfaff D, Turi S, Adler G. Vasoactive mediators and the progression from oedematous to necrotising experimental acute pancreatitis. Gut 1995; 37: 434-440.
34. Weinstein SL, Gold MR, DeFranco AL. Bacterial lipopolysaccaride stimulates protein tyrosine phosphorylation in macrophages. Proc Natl Acad Sci USA 1991; 88: 4148-4152.
35. Yotsumoto F, Manabe T, Ohshio G. Role of pancreatic blood flow and vasoactive substances in the development of canine acute pancreatitis. J Surg Res 1993; 55: 531-536.